MANGALAMNSEMangalam Drugs And Organics Limited· PharmaceuticalsHighNegative
Announced Sat, 16 May · 15:20 IST

Mangalam Drugs And Organics Limited has informed the Exchange about Fraud/Default/Arrest

Loan NpaCredit & Debt View source PDF

MANGALAM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+0.0%1-day move
₹29.95
prior close
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.0+4.0+1.8-2.0-3.1-4.2-5.2-0.4-8.8
Up moveDown movePending
AI summary

Mangalam Drugs and Organics Limited has disclosed a loan default under SEBI regulations. The company has defaulted on cash credit facilities with two banks - Bank of Maharashtra (overdue Rs. 951.97 lakhs, default since October 17, 2025) and Bank of Baroda (overdue Rs. 606.08 lakhs, default since October 20, 2025). The total overdue amount stands at Rs. 1,558.05 lakhs (approximately Rs. 15.58 crore) as of May 15, 2026. The company states it is making arrangements to pay the overdue amount as soon as possible. This is a subsequent disclosure following an earlier default intimation dated February 16, 2026.

Likely market impact

This is a significant negative development indicating financial distress. The loan default exceeding 30 days will likely result in the accounts being classified as Non-Performing Assets (NPA) by the banks, which could severely impact the company's credit rating and future borrowing ability.